Context. MAGLi 432 (Roche) is a novel, reversible monoacylglycerol lipase (MAGL) inhibitor. There has been increasing interest in the role of inflammation and blood-brain barrier dysfunction in neurology. The…
Context. MAGLi 432 (Roche) is a novel, reversible monoacylglycerol lipase (MAGL) inhibitor. There has been increasing interest in the role of inflammation and blood-brain barrier dysfunction in neurology. The…